PRESS RELEASE published on 06/03/2026 at 01:40, 2 months 3 days ago DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy DBV Technologies screens first participant in THRIVE Phase 2 study of VIASKIN Peanut Patch for infants with peanut allergy. Study aims to achieve ad lib consumption of dietary peanut in infants 6-12 months DBV Technologies Peanut Allergy Viaskin Peanut Patch Infants THRIVE Phase 2
BRIEF published on 05/13/2026 at 22:35, 2 months 23 days ago DBV Technologies Announces Details for Upcoming General Meeting DBV Technologies Food Allergies VIASKIN Patch General Meeting 2026 Shareholders Information
BRIEF published on 05/13/2026 at 22:35, 2 months 23 days ago DBV Technologies General Meeting on June 3, 2026 Shareholders General Assembly DBV Technologies Viaskin Pediatric Allergies
PRESS RELEASE published on 05/13/2026 at 22:30, 2 months 23 days ago Combined General Meeting of June 3, 2026 DBV Technologies to hold Combined General Meeting on June 3, 2026, at 10:00 a.m. CEST in Châtillon, France. Procedures for obtaining information available on company's website Webcast Preparatory Documents Combined General Meeting DBV Technologies Châtillon
BRIEF published on 05/12/2026 at 22:35, 2 months 24 days ago DBV Technologies is participating in the BioConnect Investor conference Fireside Chat DBV Technologies Viaskin Daniel Tassé BioConnect Investor
BRIEF published on 05/12/2026 at 22:35, 2 months 24 days ago DBV Technologies to Join H.C. Wainwright BioConnect Conference DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch BioConnect Nasdaq
PRESS RELEASE published on 05/12/2026 at 22:30, 2 months 24 days ago DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq DBV Technologies to participate in H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq. Presentation by CEO Daniel Tassé on May 19, 2026, at 9:00 am ET Nasdaq H.C. Wainwright DBV Technologies Food Allergies BioConnect Investor Conference
BRIEF published on 04/02/2026 at 22:35, 4 months 3 days ago DBV Technologies Reports Voting Rights and Shares as of March 31, 2026 Voting Rights Shares DBV Technologies NYSE Euronext Paris March 2026
BRIEF published on 04/02/2026 at 22:35, 4 months 3 days ago DBV Technologies: Share Capital Information as of March 31, 2026 Share Capital Voting Rights Financial Market DBV Technologies Legal Information
PRESS RELEASE published on 04/02/2026 at 22:30, 4 months 3 days ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 Press release on the total number of voting rights and shares of the company as of March 31, 2026, in compliance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers Voting Rights Shares Financial Markets Regulations NYSE Euronext Paris
Published on 08/06/2026 at 15:00, 3 hours 8 minutes ago Norsemont Strategically Expands Choquelimpie Land Package To 9,048 Hectares
Published on 08/06/2026 at 14:30, 3 hours 38 minutes ago Loar Holdings Inc. Reports Q2 2026 Record Results and Upward Revision to 2026 Outlook
Published on 08/06/2026 at 14:30, 3 hours 38 minutes ago NV Gold Announces Expansion of Holdings and Drill Program at the Slumber Gold Project in Nevada
Published on 08/06/2026 at 14:30, 3 hours 38 minutes ago AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare
Published on 08/06/2026 at 14:00, 4 hours 8 minutes ago Adcore to Publish Second Quarter 2026 Results on August 13, 2026
Published on 08/06/2026 at 17:20, 47 minutes ago Strutt Enters Europe: Expands Product Lineup with New ev¹e Variant and Showcases Evolving Smart Ecosystem at IFA 2026
Published on 08/06/2026 at 16:15, 1 hour 52 minutes ago Monotype and Kittl Expand Partnership To Bring Brand Typography Directly Into Creative Workflows
Published on 08/06/2026 at 15:20, 2 hours 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 08/06/2026 at 15:19, 2 hours 48 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 08/06/2026 at 17:45, 23 minutes ago Declaration of voting rights at the end of July 2026
Published on 08/06/2026 at 17:35, 33 minutes ago Groupe des Assurances du Crédit Mutuel (GACM)’s Solvency II ratio was 227% as of June 30, 2026
Published on 08/06/2026 at 17:35, 33 minutes ago Availability of the financial statements of Groupe des Assurances du Crédit Mutuel for the first half of 2026
Published on 08/06/2026 at 17:35, 33 minutes ago Disclosure of the number of shares and the total number of voting rights as of July 31, 2026